The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ps.36.9.939

Dr. Sbarfstein's Introduction: This month's column discusses the most important change in Medicare coverage for mentally disorders since the inception of Medicare almost 20 years ago. It provides a perspective on the benefits as well as some of the problems in making such a change. One potentially troubling implication of the new policy is that it may lead Medicare to reconceptualize mental conditions with a clearly demonstrable organic etiology as neurologic, rather than psychiatric, conditions. It is important for psychiatry to be recognized as the medical specialty that treats patients with disorders manifested as disturbances of mental processes, bebavior, and emotions. These symptoms and syndromes must be considered independent of etiology, whether it be known central nervous system pathology, developmental problems, psychosocial difficulties, toxic conditions, or otber factors. With this caveat in mind, the following discussion should interest all professionals involved in the treatment of patients with Alzheimer's disease.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.